Sale!

COL3A1 Gene Ehlers-Danlos Syndrome Type 3 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The COL3A1 Gene Ehlers-Danlos Syndrome Type 3 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the COL3A1 gene, which are associated with Ehlers-Danlos Syndrome Type 3 (EDS Type 3), also known as vascular Ehlers-Danlos Syndrome. This condition is a rare, inherited disorder that affects connective tissues, leading to symptoms such as highly elastic skin, overly flexible joints, and fragile blood vessels. The test is crucial for individuals with a family history of EDS Type 3 or those exhibiting symptoms, as it can confirm the diagnosis and help in managing the condition effectively. The cost of the test is 4400 AED, reflecting the comprehensive nature of the genetic analysis and the detailed, personalized report provided to the patient. Undergoing this test at DNA Labs UAE ensures access to state-of-the-art genetic testing technologies, expert analysis, and support throughout the diagnostic process.

Description

COL3A1 Gene Ehlers-Danlos Syndrome Type 3 Genetic Test

Components: COL3A1 Gene Ehlers-Danlos syndrome type 3 Genetic Test

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Osteology Dermatology Immunology Disorders

Doctor: Dermatologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for COL3A1 Gene Ehlers-Danlos syndrome type 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with COL3A1 Gene Ehlers-Danlos syndrome type 3 NGS Genetic DNA Test gene COL3A1

Test Details: The COL3A1 gene is responsible for providing instructions for the production of a protein called type III collagen. This protein is important for the structure and strength of connective tissues in the body, such as the skin, blood vessels, and organs. Ehlers-Danlos syndrome (EDS) type 3, also known as hypermobile EDS, is a genetic disorder characterized by joint hypermobility, skin hyperextensibility, and tissue fragility. It is caused by mutations in the COL3A1 gene, which result in the production of abnormal type III collagen or reduced amounts of this protein.

NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously and detect mutations or variations in the DNA sequence. In the context of Ehlers-Danlos syndrome type 3, NGS genetic testing can be used to identify specific mutations or variations in the COL3A1 gene that are associated with this condition. By identifying these genetic variations, NGS testing can help confirm a diagnosis of Ehlers-Danlos syndrome type 3 and provide information about the specific mutation present in an individual. This information can be useful for genetic counseling, understanding the inheritance pattern, and potentially guiding treatment decisions.

It’s important to note that genetic testing should be performed and interpreted by qualified healthcare professionals who specialize in genetics. They can provide appropriate counseling and guidance based on the test results.

Test Name	COL3A1 Gene Ehlers-Danlos syndrome type 3 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Osteology Dermatology Immunology Disorders
Doctor	Dermatologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for COL3A1 Gene Ehlers-Danlos syndrome type 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with COL3A1 Gene Ehlers-Danlos syndrome type 3 NGS Genetic DNA Test gene COL3A1
Test Details	The COL3A1 gene is responsible for providing instructions for the production of a protein called type III collagen. This protein is important for the structure and strength of connective tissues in the body, such as the skin, blood vessels, and organs. Ehlers-Danlos syndrome (EDS) type 3, also known as hypermobile EDS, is a genetic disorder characterized by joint hypermobility, skin hyperextensibility, and tissue fragility. It is caused by mutations in the COL3A1 gene, which result in the production of abnormal type III collagen or reduced amounts of this protein. NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously and detect mutations or variations in the DNA sequence. In the context of Ehlers-Danlos syndrome type 3, NGS genetic testing can be used to identify specific mutations or variations in the COL3A1 gene that are associated with this condition. By identifying these genetic variations, NGS testing can help confirm a diagnosis of Ehlers-Danlos syndrome type 3 and provide information about the specific mutation present in an individual. This information can be useful for genetic counseling, understanding the inheritance pattern, and potentially guiding treatment decisions. It’s important to note that genetic testing should be performed and interpreted by qualified healthcare professionals who specialize in genetics. They can provide appropriate counseling and guidance based on the test results.